行情

AMRN

AMRN

阿玛琳
NASDAQ

实时行情|Nasdaq Last Sale

17.17
-0.08
-0.46%
已收盘, 17:08 09/17 EDT
开盘
17.38
昨收
17.25
最高
17.55
最低
16.84
成交量
459.56万
成交额
--
52周最高
23.91
52周最低
2.650
市值
56.89亿
市盈率(TTM)
-63.6633
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AMRN 新闻

  • Portfolio Update And Trade Ideas
  • Seeking Alpha - Article.16小时前
  • 2 Small Biotech Stocks Make Citi’s Top 5 List
  • marketwatch.com.23小时前
  • Amarin Highlights New Position Statement From National Lipid Association Recognizing Cardiovascular Risk-Lowering Effects Of Icosapent Ethyl
  • Benzinga.1天前
  • National Lipid Association’s New Position Statement on Use of Icosapent Ethyl in High and Very-High-Risk Patients Recognizes Importance of Addressing Residual Cardiovascular Risk in Patients on Statins
  • GlobeNewswire.2天前

更多

所属板块

生物技术和医学研究
+0.26%
制药与医学研究
+0.57%

热门股票

名称
价格
涨跌幅

AMRN 简况

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
展开

Webull提供Amarin Corporation plc (ADR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。